Quantitative Prediction of In Vivo Drug-Drug Interactions from In Vitro Data Based on Physiological Pharmacokinetics: Use of Maximum Unbound Concentration of Inhibitor at the Inlet to the Liver
Authors:
- 1 March 2000
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 17 (3) , 336-343
Abstract
Purpose. To assess the degree to which the maximum unboundconcentration of inhibitor at the inlet to the liver (Iinlet,u,max), used in theprediction of drug-drug interactions, overestimates the...Keywords
This publication has 18 references indexed in Scilit:
- Prediction of Pharmacokinetic Alterations Caused by Drug-Drug Interactions: Metabolic Interaction in the LiverPharmacological Reviews, 1998
- QUANTITATIVE PREDICTION OF IN VIVO DRUG CLEARANCE AND DRUG INTERACTIONS FROM IN VITRO DATA ON METABOLISM, TOGETHER WITH BINDING AND TRANSPORTAnnual Review of Pharmacology and Toxicology, 1998
- In Vitro Approaches to Predicting Drug Interactions In VivoBiochemical Pharmacology, 1998
- Genetic factors influencing the metabolism of tolbutamidePharmacology & Therapeutics, 1989
- Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotypeEuropean Journal of Clinical Pharmacology, 1987
- Effect of Sulfaphenazole on Tolbutamide Distribution in Rabbits: Analysis of Interspecies Differences in Tissue Distribution of TolbutamideJournal of Pharmaceutical Sciences, 1984
- Animal scale-upJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971
- The Metabolic Fate of Tolbutamide in Man and in the RatJournal of Medicinal Chemistry, 1966
- SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICSThe Lancet, 1963